ANG Lifesciences

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE236W01016
  • NSEID:
  • BSEID: 540694
INR
26.27
-0.44 (-1.65%)
BSENSE

Feb 06

BSE+NSE Vol: 3.36 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002820,
    "name": "ANG Lifesciences",
    "stock_name": "ANG Lifesciences",
    "full_name": "ANG Lifesciences India Ltd",
    "name_url": "stocks-analysis/ang-lifesciences",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "26.27",
    "chg": -0.44,
    "chgp": "-1.65%",
    "dir": -1,
    "prev_price": "26.71",
    "mcapval": "36.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540694,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE236W01016",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "3.36 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ang-lifesciences-1002820-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3825743",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/ANGLifesciences_mojoScore_3825743.png",
        "date": "2026-02-07 10:10:32",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2023. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 07 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "When is the next results date for ANG Lifesciences India Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-ang-lifesciences-india-ltd-3825269",
        "imagepath": "",
        "date": "2026-02-06 23:18:59",
        "description": "ANG Lifesciences India Ltd is scheduled to declare its results on 14 February 2026...."
      },
      {
        "title": "ANG Lifesciences India Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-india-ltd-is-rated-strong-sell-3771074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_mojoScore_3771074.png",
        "date": "2025-12-26 15:13:06",
        "description": "ANG Lifesciences India Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 Jun 2023. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "ANG Lifesciences Sees Revision in Market Assessment Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ang-lifesciences-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3750662",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_mojoScore_3750662.png",
        "date": "2025-12-08 10:10:22",
        "description": "ANG Lifesciences has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and operational metrics. The pharmaceutical and biotechnology company’s recent assessment highlights concerns across multiple parameters, signalling a cautious outlook for investors amid persistent underperformance and financial strain."
      },
      {
        "title": "ANG Lifesciences India Surges with Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3737724",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/ANGLifesciences_only_buyers_3737724.png",
        "date": "2025-12-01 09:31:18",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum, hitting the upper circuit with only buy orders in the queue. The stock’s performance today stands out sharply against the broader market, reflecting a rare scenario of sustained demand and no selling pressure, potentially signalling a multi-day circuit phenomenon."
      },
      {
        "title": "Why is ANG Lifesciences falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ang-lifesciences-fallingrising-3736244",
        "imagepath": "",
        "date": "2025-11-29 01:02:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>ANG Lifesciences has recorded a consecutive three-day rally, accumulating a 15.67% return during this period. Today's session opened with a gap up of 4.95%, signalling strong buying interest at the outset. The stock outperformed its sector by 4.44% today, indicating relative strength compared to its peers. Intraday, the price fluctuated between a low of ₹25.70 and a high of ₹27.98, ultimately settling at the day's peak level.</p>\n<p>Despite this recent upswing, the stock's longer-term performance remains subdued. Year-to-date, ANG Lifesciences has declined by 37.39%, contrasting sharply with the Sensex's 9.68% gain over the same period. Over one year, the stock is down 37.82%, while the Sensex has advanced 8.43%. The three-year tre..."
      },
      {
        "title": "ANG Lifesciences India Sees Unprecedented Buying Interest Amid Upper Circuit Lock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3735403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3735403.png",
        "date": "2025-11-28 10:20:36",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike."
      },
      {
        "title": "ANG Lifesciences India Sees Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3732947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3732947.png",
        "date": "2025-11-27 09:41:34",
        "description": "ANG Lifesciences India has witnessed extraordinary buying momentum today, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon highlights intense demand and the possibility of a sustained multi-day circuit scenario, setting the stage for close investor attention in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "ANG Lifesciences India Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ang-lifesciences-india-hits-upper-circuit-amid-unprecedented-buying-interest-3731342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/ANGLifesciences_only_buyers_3731342.png",
        "date": "2025-11-26 11:45:33",
        "description": "ANG Lifesciences India has witnessed a remarkable surge in buying activity, with the stock hitting the upper circuit and registering only buy orders in the queue. This unusual market behaviour signals intense demand and the possibility of a multi-day circuit scenario, drawing significant attention from investors and market watchers alike."
      }
    ],
    "total": 286,
    "sid": "1002820",
    "stock_news_url": "https://www.marketsmojo.com/news/ang-lifesciences-india-1002820"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended And Nine Months Ended On 31St December 2025.",
      "datetime": "05-Feb-2026",
      "details": "ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "22-Jan-2026",
      "details": "Disclosure under Reg. 74(5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "22-Dec-2025",
      "details": "Closure of Trading Window.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has declared <strong>10%</strong> dividend, ex-date: 02 Nov 21",
          "dt": "2021-11-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "ANG Lifesciences India Ltd has announced <strong>1:4</strong> bonus issue, ex-date: 13 Jul 22",
          "dt": "2022-07-13",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is ANG Lifesciences falling/rising?

2025-11-29 01:02:50

Short-Term Price Movement and Market Context

ANG Lifesciences has recorded a consecutive three-day rally, accumulating a 15.67% return during this period. Today's session opened with a gap up of 4.95%, signalling strong buying interest at the outset. The stock outperformed its sector by 4.44% today, indicating relative strength compared to its peers. Intraday, the price fluctuated between a low of ₹25.70 and a high of ₹27.98, ultimately settling at the day's peak level.

Despite this recent upswing, the stock's longer-term performance remains subdued. Year-to-date, ANG Lifesciences has declined by 37.39%, contrasting sharply with the Sensex's 9.68% gain over the same period. Over one year, the stock is down 37.82%, while the Sensex has advanced 8.43%. The three-year tre...

Read full news article
stock-recommendationAnnouncement

Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended And Nine Months Ended On 31St December 2025.

05-Feb-2026 | Source : BSE

ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2025.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

22-Jan-2026 | Source : BSE

Disclosure under Reg. 74(5) of SEBI (DP) Regulations 2018.

Closure of Trading Window

22-Dec-2025 | Source : BSE

Closure of Trading Window.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

14 Feb 2026

stock-summary
DIVIDEND

ANG Lifesciences India Ltd has declared 10% dividend, ex-date: 02 Nov 21

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

ANG Lifesciences India Ltd has announced 1:4 bonus issue, ex-date: 13 Jul 22

stock-summary
RIGHTS

No Rights history available